ArticleNature communications2026

Engineered BCG selectively triggers trained immunity in tumor-associated macrophages and sensitizes glioblastoma to radiotherapy in mice.

Ke Ren et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.